Allergan
This article was originally published in The Gray Sheet
Executive Summary
Plans to repurchase up to 3.6 mil. shares of common stock "for the company's treasury." The firm has repurchased over 3.2 mil. shares since July 1989. As of July 31 of this year, 66.2 mil. shares were outstanding.